Health officials say the Centers for Disease Control and Prevention is giving the go-ahead for the first U.K.-based vaccine in the world.
The U.N. body has been preparing for the introduction of the new disease-fighting vaccine for more than two decades.
It was initially intended to be available by 2020, but a series of delays have made it more distant.
The vaccine was developed by Sanofi Pasteur and Pfizer.
Its developers say they will be working with the government and other partners to reach an eventual goal of making the vaccine available to all U.KS.
The U.B.C. is the only U.UK health authority to have developed the vaccine.
According to a news release from the UBS Healthcare Information Systems, the UB-led project will target “a large number of patients, especially those at risk of developing secondary disseminated MS and associated neurological symptoms, including those in intensive care units.”
The UBS news release also said the vaccine will be developed in collaboration with the British National Institute for Health Research, which will also provide clinical support.
Dr. Peter Fauci, the director of the National Institute of Neurological Disorders and Stroke (NINDS), said the agency is committed to getting the vaccine to the U